# PRDM12

## Overview
PRDM12 is a gene located on human chromosome 9, which encodes the protein PR/SET domain 12. This protein is a transcriptional regulator involved in the development of nociceptive sensory neurons, crucial for the perception of pain, temperature, and itch. PR/SET domain 12 is characterized by a PR domain related to the SET methyltransferase domain and multiple zinc finger motifs, indicating its role in chromatin modification and gene expression regulation (Chen2015Transcriptional; Mehmood2020Structural). The protein operates primarily in the nucleus, influencing the transcriptional landscape necessary for sensory neuron differentiation and function. Mutations in the PRDM12 gene are linked to congenital insensitivity to pain and other sensory neuropathies, highlighting its critical role in sensory perception and neuronal development (Rienzo2021PRDM12).

## Structure
PRDM12 is a protein encoded by the human PRDM12 gene, characterized by a primary structure consisting of 367 amino acids. This protein includes a PR domain related to the SET methyltransferase domain and three zinc finger motifs, which are typical of DNA-binding transcription factors (Chen2015Transcriptional; Mehmood2020Structural). The PR domain spans amino acids 86 to 203, while the zinc finger domains are located between amino acids 243-265, 271-293, and 299-323 (Rienzo2021PRDM12).

The tertiary structure of PRDM12 has been modeled using homology modeling techniques, predicting the overall folding pattern of the protein (Mehmood2020Structural). However, detailed information on the secondary structure, such as specific alpha-helices and beta-sheets, or the quaternary structure, such as protein complex assembly, is not provided in the available literature.

Post-translational modifications predicted for PRDM12 include phosphorylation sites, which could be crucial for its function, although no glycosylation sites were predicted (Mehmood2020Structural). The protein's interaction with other proteins, such as PRDM8, suggests its involvement in complex biological pathways (Mehmood2020Structural).

Overall, while some aspects of PRDM12's molecular structure and post-translational modifications are characterized, detailed insights into its secondary and quaternary structures remain limited based on the current literature.

## Function
PRDM12 is a transcriptional regulator that plays a pivotal role in the development and function of nociceptive sensory neurons, which are essential for the perception of pain, temperature, and itch. The gene is expressed in neural crest cells during early embryonic development and is crucial for initiating the sensory neuronal differentiation program that leads to the formation of the nociceptive lineage (Bartesaghi2019PRDM12). PRDM12 specifically regulates the expression of the nerve growth factor (NGF) receptor TrkA (encoded by Ntrk1), which is necessary for the survival and differentiation of nociceptors (Desiderio2019Prdm12). 

The protein encoded by PRDM12 contains several domains, including SET domains and multiple Zinc Finger C2H2 domains, suggesting its role in histone methylation and gene regulation (Mehmood2020Structural). This regulatory activity is crucial for the transcriptional regulation necessary for the development of nociceptive neurons. PRDM12 operates within the nucleus, where it modifies chromatin structure and regulates gene expression critical for neuronal development and differentiation (Mehmood2020Structural). 

Mutations in PRDM12 have been linked to congenital insensitivity to pain, underscoring its critical role in sensory functions and pain perception (Rienzo2021PRDM12). The gene's function involves the regulation of histone methylation, which is important for the transcriptional regulation necessary for the development of nociceptive neurons (Rienzo2021PRDM12).

## Clinical Significance
PRDM12 mutations are primarily associated with congenital insensitivity to pain (CIP) and hereditary sensory and autonomic neuropathy type VIII (HSAN8), conditions characterized by an inability to perceive pain, leading to severe injuries and infections without pain awareness. These mutations can result in various symptoms including painless injuries, ulcerations, and frequent bacterial skin infections. Intellectual disability is variable among affected individuals (Lischka2022Genetic; Imhof2020PRDM12). PRDM12 is also linked to Midface Toddler Excoriation Syndrome (MiTES), a severe condition involving chronic, scarring, self-inflicted facial excoriations starting in infancy, suggesting a broader spectrum of sensory impairments associated with PRDM12 mutations (Moss2018Midface).

In addition to sensory neuropathies, PRDM12 has implications in cancer biology. It is suggested to function as a tumor suppressor gene in chronic myeloid leukemia (CML), where deletions involving PRDM12 are linked to an aggressive phenotype and shorter survival. Furthermore, PRDM12 is upregulated in several other cancer types, including colon, breast, and lung cancers, indicating its potential role as a tumor marker (Rienzo2021PRDM12).

These associations underscore the critical role of PRDM12 in both the development of nociceptive sensory neurons and potentially in tumorigenesis, highlighting the gene's importance in medical genetics and disease pathology.

## Interactions
PRDM12 interacts with various proteins and potentially nucleic acids, playing a significant role in transcription regulation and cellular differentiation. PRDM12 lacks intrinsic histone lysine methyltransferase activity but can recruit the H3K9 methyltransferase, G9a, to facilitate the dimethylation of histone H3 at lysine 9 (H3K9me2), a modification associated with transcriptional repression (Rienzo2021PRDM12). This interaction is mediated by PRDM12's zinc finger domains in mouse and Xenopus models, suggesting a mechanism by which PRDM12 influences chromatin structure and gene expression indirectly (Rienzo2021PRDM12).

Additionally, PRDM12 interacts with other proteins such as Kdm4a, affecting H3K9 methylation levels on neural crest gene promoters (Rienzo2021PRDM12). It also interacts with EHMT2/G9a and Bhlhe22 through its zinc-finger domain in zebrafish, although Bhlhe22 is not required for eng1b expression (Rienzo2021PRDM12). Furthermore, PRDM12 is a downstream target of the ZIC1 transcription factor, which controls its expression through Wnt signaling during brain cell differentiation (Rienzo2021PRDM12).

In the context of protein-protein interactions, PRDM12 has been shown to interact with PRDM8, as revealed by analysis using the STRING platform (Mehmood2020Structural). These interactions highlight PRDM12's role in transcriptional regulation and its involvement in cellular signaling pathways, impacting processes such as neurogenesis and differentiation.


## References


[1. (Bartesaghi2019PRDM12) Luca Bartesaghi, Yiqiao Wang, Paula Fontanet, Simone Wanderoy, Finja Berger, Haohao Wu, Natalia Akkuratova, Filipa BouÃ§anova, Jean-Jacques MÃ©dard, Charles PetitprÃ©, Mark A. Landy, Ming-Dong Zhang, Philip Harrer, Claudia Stendel, Rolf Stucka, Marina Dusl, Maria Eleni Kastriti, Laura Croci, Helen C. Lai, Gian Giacomo Consalez, Alexandre Pattyn, Patrik Ernfors, Jan Senderek, Igor Adameyko, Francois Lallemend, Saida Hadjab, and Roman Chrast. Prdm12 is required for initiation of the nociceptive neuron lineage during neurogenesis. Cell Reports, 26(13):3484-3492.e4, March 2019. URL: http://dx.doi.org/10.1016/j.celrep.2019.02.098, doi:10.1016/j.celrep.2019.02.098. (44 citations) 10.1016/j.celrep.2019.02.098](https://doi.org/10.1016/j.celrep.2019.02.098)

[2. (Chen2015Transcriptional) Ya-Chun Chen, Michaela Auer-Grumbach, Shinya Matsukawa, Manuela Zitzelsberger, Andreas C Themistocleous, Tim M Strom, Chrysanthi Samara, Adrian W Moore, Lily Ting-Yin Cho, Gareth T Young, Caecilia Weiss, Maria SchabhÃ¼ttl, Rolf Stucka, Annina B Schmid, Yesim Parman, Luitgard Graul-Neumann, Wolfram Heinritz, Eberhard Passarge, Rosemarie M Watson, Jens Michael Hertz, Ute Moog, Manuela Baumgartner, Enza Maria Valente, Diego Pereira, Carlos M Restrepo, Istvan Katona, Marina Dusl, Claudia Stendel, Thomas Wieland, Fay Stafford, Frank Reimann, Katja von Au, Christian Finke, Patrick J Willems, Michael S Nahorski, Samiha S Shaikh, OfÃ©lia P Carvalho, Adeline K Nicholas, Gulshan Karbani, Maeve A McAleer, Maria Roberta Cilio, John C McHugh, Sinead M Murphy, Alan D Irvine, Uffe Birk Jensen, Reinhard Windhager, Joachim Weis, Carsten Bergmann, Bernd Rautenstrauss, Jonathan Baets, Peter De Jonghe, Mary M Reilly, Regina Kropatsch, Ingo Kurth, Roman Chrast, Tatsuo Michiue, David L H Bennett, C Geoffrey Woods, and Jan Senderek. Transcriptional regulator prdm12 is essential for human pain perception. Nature Genetics, 47(7):803â808, May 2015. URL: http://dx.doi.org/10.1038/ng.3308, doi:10.1038/ng.3308. (179 citations) 10.1038/ng.3308](https://doi.org/10.1038/ng.3308)

[3. (Mehmood2020Structural) Sarmad Mehmood, Rubina Dad, Arsalan Ahmad, Muhammad Ikram Ullah, Peter John, Amjad Ali, Christian A. Hubner, Aisha Mohyuddin, and Muhammad Jawad Hassan. Structural and functional annotation of pr/set domain (prdm) protein family: in-silico study elaborating role of prdm12 mutation in congenital insensitivity to pain. Computational Biology and Chemistry, 89:107382, December 2020. URL: http://dx.doi.org/10.1016/j.compbiolchem.2020.107382, doi:10.1016/j.compbiolchem.2020.107382. (3 citations) 10.1016/j.compbiolchem.2020.107382](https://doi.org/10.1016/j.compbiolchem.2020.107382)

[4. (Desiderio2019Prdm12) Simon Desiderio, Simon Vermeiren, Claude Van Campenhout, Sadia Kricha, Elisa Malki, Sven Richts, Emily V. Fletcher, Thomas Vanwelden, Bela Z. Schmidt, Kristine A. Henningfeld, Tomas Pieler, C. Geoffrey Woods, Vanja Nagy, Catherine Verfaillie, and Eric J. Bellefroid. Prdm12 directs nociceptive sensory neuron development by regulating the expression of the ngf receptor trka. Cell Reports, 26(13):3522-3536.e5, March 2019. URL: http://dx.doi.org/10.1016/j.celrep.2019.02.097, doi:10.1016/j.celrep.2019.02.097. (55 citations) 10.1016/j.celrep.2019.02.097](https://doi.org/10.1016/j.celrep.2019.02.097)

[5. (Moss2018Midface) C. Moss, S.M. Srinivas, N. Sarveswaran, M. Nahorski, V.K. Gowda, F.M. Browne, and G. Woods. Midface toddler excoriation syndrome (mites) can be caused by autosomal recessive biallelic mutations in a gene for congenital insensitivity to pain, prdm12. British Journal of Dermatology, 179(5):1135â1140, September 2018. URL: http://dx.doi.org/10.1111/bjd.16893, doi:10.1111/bjd.16893. (21 citations) 10.1111/bjd.16893](https://doi.org/10.1111/bjd.16893)

[6. (Lischka2022Genetic) Annette Lischka, Petra Lassuthova, Arman Ãakar, Christopher J. Record, Jonas Van Lent, Jonathan Baets, Maike F. Dohrn, Jan Senderek, Angelika Lampert, David L. Bennett, John N. Wood, Vincent Timmerman, Thorsten Hornemann, Michaela Auer-Grumbach, Yesim Parman, Christian A. HÃ¼bner, Miriam Elbracht, Katja Eggermann, C. Geoffrey Woods, James J. Cox, Mary M. Reilly, and Ingo Kurth. Genetic pain loss disorders. Nature Reviews Disease Primers, June 2022. URL: http://dx.doi.org/10.1038/s41572-022-00365-7, doi:10.1038/s41572-022-00365-7. (18 citations) 10.1038/s41572-022-00365-7](https://doi.org/10.1038/s41572-022-00365-7)

[7. (Rienzo2021PRDM12) Monica Rienzo, Erika Di Zazzo, Amelia Casamassimi, Patrizia Gazzerro, Giovanni Perini, Maurizio Bifulco, and Ciro Abbondanza. Prdm12 in health and diseases. International Journal of Molecular Sciences, 22(21):12030, November 2021. URL: http://dx.doi.org/10.3390/ijms222112030, doi:10.3390/ijms222112030. (11 citations) 10.3390/ijms222112030](https://doi.org/10.3390/ijms222112030)